AC Immune (ACIU) Current Assets (2015 - 2026)

AC Immune (ACIU) has 12 years of Current Assets data on file, last reported at $102.2 billion in Q1 2026.

• On a quarterly basis, Current Assets rose 60314.5% year-over-year to $102.2 billion in Q1 2026; TTM through Mar 2026 was $102.2 billion, a 60314.5% increase from a year earlier, with the FY2025 full-year figure at $116.7 billion, up 59318.45% from the prior year.
• Current Assets for Q1 2026 stood at $102.2 billion, down from $121.0 billion in the prior quarter.
• Over the last five years, Current Assets for ACIU reached as high as $191.7 billion in Q1 2022 and fell as low as $97.6 million in Q3 2023.
• Historically, Current Assets has averaged $42.5 billion across 5 years, with a median of $169.2 million in 2025.
• Across the five-year window, Current Assets tumbled 99.94% in 2022 and surged 106012.48% in 2023, its largest moves.
• Year by year, Current Assets stood at $133.0 million in 2022, then jumped by 106012.48% to $141.1 billion in 2023, then slumped by 99.86% to $196.3 million in 2024, then surged by 61537.35% to $121.0 billion in 2025, then fell by 15.52% to $102.2 billion in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $102.2 billion in Q1 2026, $121.0 billion in Q4 2025, and $142.2 million in Q3 2025.